Zenas BioPharma, Inc.
ZBIO
$16.91
-$0.02-0.12%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 48.58% | 740.77% | 516.93% | 434.91% | -- |
| Total Receivables | -- | 70.00% | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 15.97% | 140.36% | 86.22% | 59.89% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 60.77% | -- | -- |
| Total Current Assets | 47.72% | 700.42% | 495.15% | 413.56% | -- |
|
|
|||||
| Total Current Assets | 47.72% | 700.42% | 495.15% | 413.56% | -- |
| Net Property, Plant & Equipment | 51.70% | 50.65% | 17.26% | -52.48% | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 10.81% | 51.17% | 74.63% | 52.61% | -- |
| Total Assets | 46.58% | 580.45% | 442.63% | 381.47% | -- |
|
|
|||||
| Total Accounts Payable | -5.11% | 131.96% | 217.57% | 562.65% | -- |
| Total Accrued Expenses | 49.77% | 45.47% | 130.29% | 124.69% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 60.53% | 75.97% | 41.19% | -34.13% | -- |
| Total Finance Division Other Current Liabilities | -- | -99.72% | -29.90% | -- | -- |
| Total Other Current Liabilities | -- | -99.72% | -29.90% | -- | -- |
| Total Current Liabilities | 36.15% | 61.98% | 146.33% | 182.81% | -- |
|
|
|||||
| Total Current Liabilities | 36.15% | 61.98% | 146.33% | 182.81% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 1,435.71% | 138.35% | -15.18% | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 36.65% | -3.91% | 31.26% | 22.42% | -- |
|
|
|||||
| Common Stock & APIC | 9,673.88% | 12,415.80% | 14,962.54% | 19,962.63% | -- |
| Retained Earnings | -59.76% | -63.04% | -68.14% | -62.66% | -- |
| Treasury Stock & Other | -190.38% | 90.54% | 424.32% | -56.45% | -- |
| Total Common Equity | 182.98% | 212.60% | 238.43% | 277.73% | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 182.98% | 212.60% | 238.43% | 277.73% | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.99% | 11,902.28% | 1,182.41% | 651.11% | -- |
|
|
|||||